RxDoctor Payments Data

Wayne Plooster, DO

Family Medicine · Rapid City, SDNPI 1013101054

Payments from drug & device makers

$315in general payments, 2019–2025

Across 17 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$101
  • GSK$94
  • E.r. Squibb & Sons, L.L.C.$46
  • Inspire Medical Systems, Inc.$43
  • Novo Nordisk$16
  • Eisai Inc.$15

What the payments were for

  • Food & beverage$315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$315 in reported general payments places this provider in the 60th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$289,102
Medicare patients
622
Services billed
9,111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin75$75,139
EliquisApixaban78$69,331
XareltoRivaroxaban52$58,289
GlyxambiEmpagliflozin/Linagliptin36$36,723
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$32,321
Tresiba Flextouch U-200Insulin Degludec28$19,746
JanuviaSitagliptin Phosphate14$19,393
FarxigaDapagliflozin Propanediol16$18,542
MounjaroTirzepatide15$17,240
Stiolto RespimatTiotropium Br/Olodaterol Hcl30$14,824
OzempicSemaglutide14$12,922
Rosuvastatin Calcium473$11,592
Breo ElliptaFluticasone/Vilanterol20$9,597
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$8,801
SymbicortBudesonide/Formoterol Fumarate25$7,930

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$94$47,57772 claims
Novo NordiskOzempic$16$12,92214 claims
AbbVieLinzess$101$6,72912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →